Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030

BACKGROUND: Persistent activation of signal transducers and activators of transcription 3 (STAT3) is commonly detected in many types of cancer, including colon cancer. To date, whether STAT3 is activated and the effects of STAT3 inhibition by a newly developed curcumin analogue, GO-Y030, in colon ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, L, Liu, Y, Li, H, Li, P-K, Fuchs, J, Shibata, H, Iwabuchi, Y, Lin, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142799/
https://www.ncbi.nlm.nih.gov/pubmed/21694723
http://dx.doi.org/10.1038/bjc.2011.200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142799/
https://www.ncbi.nlm.nih.gov/pubmed/21694723
http://dx.doi.org/10.1038/bjc.2011.200

Ejemplares similares